NF-κB in colorectal cancer (Q38103447)

28 August 2017

NF-κB in colorectal cancer (English)

1 reference

28 August 2017

0 references

1 reference

Aristeidis G Vaiopoulos

series ordinal

1

1 reference

28 August 2017

Kalliopi Ch Athanasoula

series ordinal

2

1 reference

28 August 2017

Athanasios G Papavassiliou

series ordinal

3

1 reference

28 August 2017

1 May 2013

1 reference

Journal of Molecular Medicine

28 August 2017

1 reference

28 August 2017

91

1 reference

28 August 2017

9

1 reference

28 August 2017

1029-1037

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-013-1045-x

28 August 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Colon carcinogenesis: Learning from NF-kappaB and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

It takes two to tango: IκBs, the multifunctional partners of NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Hierarchies of NF-κB target-gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

NF-κB in cancer: a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

NF-kappaB and cancer: how intimate is this relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

NF-κB addiction and its role in cancer: 'one size does not fit all'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

p53-independent roles of MDM2 in NF-κB signaling: implications for cancer therapy, wound healing, and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Inflammation meets cancer, with NF-κB as the matchmaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Role of NF-κB in epithelial biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Inflammation and colorectal cancer: colitis-associated neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Cytokines, inflammation and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Inflammation and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Intestinal carcinogenesis: IKK can go all the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Multifaceted link between cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Colorectal cancer mouse models: integrating inflammation and the stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

KRAS mutation and NF-κB activation indicates tolerance of chemotherapy and poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

The NF-κB target genes ICAM-1 and VCAM-1 are differentially regulated during spontaneous differentiation of Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kappaB signaling pathway in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Inhibition of NF-κB signaling as a strategy in disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Targeting the inflammatory pathways to enhance chemotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Gallotannin inhibits NFĸB signaling and growth of human colon cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1045-X

Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases

21 January 2018

1 reference

12 December 2020

Effect of NF-κB inhibitors on the chemotherapy-induced apoptosis of the colon cancer cell line HT-29.

1 reference

12 December 2020

NF-κB and cancer: a paradigm of Yin-Yang.

1 reference

12 December 2020

NFκB/p53 crosstalk-a promising new therapeutic target.

1 reference

12 December 2020

NF-κB activity is downregulated by KRAS knockdown in SW620 cells via the RAS-ERK-IκBα pathway

1 reference

12 December 2020

Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2

1 reference

12 December 2020

The diverse and complex roles of NF-κB subunits in cancer

1 reference

12 December 2020

Oligonucleotides decoy to NF-kappaB: becoming a reality?

1 reference

12 December 2020

Colon cancer-derived factors activate NF-κB in myeloid cells via TLR2 to link inflammation and tumorigenesis.

1 reference

12 December 2020

Notch1 expression, which is related to p65 Status, is an independent predictor of prognosis in colorectal cancer

1 reference

12 December 2020

NFkappaB: a promising target for natural products in cancer chemoprevention

1 reference

12 December 2020

Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells.

1 reference

12 December 2020

Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells

1 reference

12 December 2020

10.1007/S00109-013-1045-X

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference